MedTrace Logo

Heart Failure (HF) Interatrial Shunt Study 1

NCT02511912 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-10-10

No results posted yet for this study

Summary

The objective of this study, is to assess the safety and performance of an interatrial shunt when implanted in patients with severe chronic heart failure.

Conditions

Interventions

PROCEDURE

V-Wave

The V-Wave shunt implantation procedure is a standard femoral venous access and inter-atrial septal puncture intervention. The shunt is placed through the Fossa Ovalis.

Sponsors & Collaborators

  • V-Wave Ltd

    lead INDUSTRY

Principal Investigators

  • Olivia Mishall · V-Wave Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-31
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Israel

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02511912 on ClinicalTrials.gov